221 related articles for article (PubMed ID: 9888451)
1. Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis.
Kitaichi N; Kotake S; Sasamoto Y; Namba K; Matsuda A; Ogasawara K; Onoé K; Matsuda H; Nishihira J
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):247-50. PubMed ID: 9888451
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum levels of CXCL9/monokine induced by interferon-gamma and CXCL10/interferon-gamma-inducible protein-10 in ocular sarcoidosis.
Takeuchi M; Oh-I K; Suzuki J; Hattori T; Takeuchi A; Okunuki Y; Usui Y; Usui M
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1063-8. PubMed ID: 16505042
[TBL] [Abstract][Full Text] [Related]
3. Immunological aspects of Behçet's and Vogt-Koyanagi-Harada's diseases.
Ohno S
Trans Ophthalmol Soc U K (1962); 1981 Sep; 101 (Pt 3)(3):335-41. PubMed ID: 6820735
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor in uveitis.
Kotake S; Kitaichi N; Ohno S
Int Ophthalmol Clin; 2002; 42(1):99-103. PubMed ID: 12189621
[TBL] [Abstract][Full Text] [Related]
5. Increased serum levels of macrophage migration inhibitory factor in patients with Kawasaki disease.
Lee TJ; Chun JK; Yeon SI; Shin JS; Kim DS
Scand J Rheumatol; 2007; 36(3):222-5. PubMed ID: 17657678
[TBL] [Abstract][Full Text] [Related]
6. Behçet's disease and streptococcal infection.
Namba K; Ueno T; Okita M
Jpn J Ophthalmol; 1986; 30(4):385-401. PubMed ID: 3586405
[TBL] [Abstract][Full Text] [Related]
7. Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behçet's disease and Vogt-Koyanagi-Harada's disease.
Uchio E; Matsumoto T; Tanaka SI; Ohno S
Clin Exp Rheumatol; 1999; 17(2):179-84. PubMed ID: 10342043
[TBL] [Abstract][Full Text] [Related]
8. Immunological studies on Behçet's and Harada's diseases. I. Cell-mediated immunity in Behçet's and Harada's diseases. II. HL-A antigens associated with Behçet's disease.
Sugiura S; Sanefuji M; Ohno S
Mod Probl Ophthalmol; 1976; 16():267-78. PubMed ID: 1250232
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
Sprong T; Pickkers P; Geurts-Moespot A; van der Ven-Jongekrijg J; Neeleman C; Knaup M; Leroy D; Calandra T; van der Meer JW; Sweep F; van Deuren M
Shock; 2007 May; 27(5):482-7. PubMed ID: 17438452
[TBL] [Abstract][Full Text] [Related]
10. Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy.
Tashimo A; Mitamura Y; Nagai S; Nakamura Y; Ohtsuka K; Mizue Y; Nishihira J
Diabet Med; 2004 Dec; 21(12):1292-7. PubMed ID: 15569131
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of intraocular inflammation in Hokkaido, Japan.
Kitamei H; Kitaichi N; Namba K; Kotake S; Goda C; Kitamura M; Miyazaki A; Ohno S
Acta Ophthalmol; 2009 Jun; 87(4):424-8. PubMed ID: 18652578
[TBL] [Abstract][Full Text] [Related]
12. Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome.
Willeke P; Gaubitz M; Schotte H; Maaser C; Domschke W; Schlüter B; Becker H
Arthritis Res Ther; 2007; 9(2):R43. PubMed ID: 17470266
[TBL] [Abstract][Full Text] [Related]
13. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
[TBL] [Abstract][Full Text] [Related]
14. Elevation of surfactant protein D, a pulmonary disease biomarker, in the sera of uveitis patients with sarcoidosis.
Kitaichi N; Kitamura M; Namba K; Ishida S; Ohno S
Jpn J Ophthalmol; 2010 Jan; 54(1):81-4. PubMed ID: 20151281
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progression.
Muramaki M; Miyake H; Yamada Y; Hara I
Oncol Rep; 2006 Jan; 15(1):253-7. PubMed ID: 16328065
[TBL] [Abstract][Full Text] [Related]
16. Marked elevation of serum macrophage migration inhibitory factor levels in patients with pemphigus vulgaris.
Namazi MR; Fallahzadeh MK; Shaghelani H; Kamali-Sarvestani E
Int J Dermatol; 2010 Feb; 49(2):146-8. PubMed ID: 19799642
[TBL] [Abstract][Full Text] [Related]
17. High-dose corticosteroid administration induces increase of serum macrophage migration inhibitory factor in patients with Vogt-Koyanagi-Harada's disease.
Kitaichi N; Kotake S; Mizue Y; Sasamoto Y; Goda C; Iwabuchi K; Onoé K; Matsuda H; Nishihira J
Microbiol Immunol; 2000; 44(12):1075-7. PubMed ID: 11220683
[TBL] [Abstract][Full Text] [Related]
18. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
Radstake TR; Sweep FC; Welsing P; Franke B; Vermeulen SH; Geurts-Moespot A; Calandra T; Donn R; van Riel PL
Arthritis Rheum; 2005 Oct; 52(10):3020-9. PubMed ID: 16200611
[TBL] [Abstract][Full Text] [Related]
19. Elevated macrophage migration inhibitory factor (MIF) levels in the urine of patients with focal glomerular sclerosis.
Matsumoto K; Maruyama N; Maruyama T; Ohnishi Y; Nonaka S; Inoshita A; Ito K; Kitajima S; Abe M; Satomura A; Fujita T
Clin Exp Immunol; 2005 Feb; 139(2):338-47. PubMed ID: 15654833
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia.
Todros T; Bontempo S; Piccoli E; Ietta F; Romagnoli R; Biolcati M; Castellucci M; Paulesu L
Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):162-6. PubMed ID: 15894418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
